Proteomics and Biomedicine Group, The University of Auckland
The research interests of the Proteomics and Biomedicine Research group include diabetes, cardiovascular and metabolic diseases, human immunology, and neurodegenerative disorders.
Proteomics and Biomedicine Group is part of the School of Biological Sciences at The University of Auckland.
The Proteomics and Biomedicine Group use proteomics, ultrastructural imaging, and cellular and molecular biology techniques to dissect the mechanisms of metabolic diseases. They are also using proteomic techniques for targeted discovery of novel bioactive peptides to develop new therapies.
The Proteomics and Biomedicine Group main research looks at two diseases:
- Diabetes - This research aims to discover new hormones that may be important in the pathophysiology of diabetes mellitus. It is multi disciplinary and involves physiology, pharmacology, proteomics, and cellular and molecular biology techniques.
- Cancer - They are developing new therapeutic vaccines for use in patients with melanoma. These vaccines are designed to stimulate the patients' own immune system to kill melanoma cells. They are also using proteomic techniques to study the molecular mechanisms involved in communication between human immune cells. This work aims to develop new methods for modulating immune responses in humans.
- Web Address:
Proteomic and Biomedicine Group
The University of Auckland
Private Bag 92019
Phone: +64 9 373 7599 ext 87297
Fax: +64 9 373 7445
- Research, development and teaching in human health and disease.
- 07 November 2007